Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Development of therapeutics targeting CXCR4 accelerated at Northwest Biotherapeutics

April 10, 2001

InKine awarded NIH grant to support angiogenesis inhibitor research

April 9, 2001

Atrix grants European marketing rights for Leuprogel to MediGene

April 9, 2001

Epothilone B derivative CGP-85715 characterized in vitro and in vivo

April 9, 2001

PNU-252808 associated with blockade of cell cycle progression and induction of apoptosis

April 9, 2001

Vasogen commences chronic lymphocytic leukemia clinical trial in Canada

April 9, 2001

Newly issued patent covers thymidylate synthase inhibitors synthesized at SUNY

April 6, 2001

Tularik's arylsulfonanilide derivatives useful as pharmacologically active agents

April 6, 2001

Antitumor isophosphoramide mustard analogues designed at Southern Research Institute

April 6, 2001

Identification of a small molecule targeting CDK4 with promise for treating tumors

April 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...